TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, announced a $150K pre-seed investment fro...
PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on i...
Marks AbbVie's largest-ever capital investment in a single campus since its inception Investment demonstrates continued progress a...
10x Science, which builds frontier AI for molecular-level protein characterization across the life sciences, today announced the closing of its $4.8M seed ...
Marks the second major investment at the Slovenská Ľupča site in recent years Follows the group’s strategy to strengthen leading ...
Sana and Mayo Clinic to collaborate across multiple areas with goal of accelerating development of and access to potentially curative therapies for patie...
Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD...
A pivotal step in PharmaEssentia's dual-site U.S.-Taiwan manufacturing strategy, with 2027 operations in sight PharmaEssentia Corporation (TWS...
H2 Global Group is strengthening its position as a European technology group connecting capital with clinically validated healthcare innovations. A prime...
Lilly to gain ownership of Centessa's OX2R agonist pipeline designed to improve outcomes across sleep-wake disorders Centessa’s OX2R agonist pip...
Stratum Biosciences, a biotechnology pioneer at the intersection of artificial intelligence and dermatology research, announced the closing of a $2...
Emergent BioSolutions Inc. announced it has secured a contract award valued at approximately $54 million USD to deliver CNJ-016® [Vaccinia Immune Glo...
Wilmington PharmaTech (“Wilmington”), a leading U.S.-based research, development, and manufacturing organization (CRDMO) focused on complex c...
Gilead Sciences, Inc. (Nasdaq: GILD) announced it has entered into a definitive agreement to acquire Ouro Medicines, a privately held biotechnology...
© 2026 Biopharma Boardroom. All Rights Reserved.
